AI
MEDP icon

Atria Investments’s Medpace MEDP Stock Holding History

Atria Investments’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
1,907
-3,740
-66% -$1.73M 0.01% 1109
2026
Q1 		$2.71M Buy
5,647
+234
+4% +$120K 0.03% 576
2025
Q4 		$3.04M Buy
5,413
+1,198
+28% +$680K 0.03% 557
2025
Q3 		$2.17M Buy
4,215
+1,136
+37% +$496K 0.02% 691
2025
Q2 		$966K Buy
3,079
+221
+8% +$66.3K 0.01% 1054
2025
Q1 		$871K Buy
2,858
+297
+12% +$99.9K 0.01% 1054
2024
Q4 		$851K Sell
2,561
-849
-25% -$288K 0.01% 1064
2024
Q3 		$1.14M Sell
3,410
-1,373
-29% -$522K 0.01% 903
2024
Q2 		$1.97M Sell
4,783
-217
-4% -$85.9K 0.03% 648
2024
Q1 		$2.02M Sell
5,000
-45
-0.9% -$15.8K 0.03% 653
2023
Q4 		$1.55M Buy
5,045
+862
+21% +$233K 0.02% 702
2023
Q3 		$1.01M Buy
+4,183
New +$1.07M 0.02% 838
2018
Q4 		– Sell
-4,099
Closed -$246K – 971
2018
Q3 		$246K Buy
+4,099
New +$224K 0.01% 850
2018
Q1 		– Sell
-5,822
Closed -$211K – 899
2017
Q4 		$211K Buy
+5,822
New +$204K 0.01% 758

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Atria Investments's MEDP Position: Q2 2026 in Review

Atria Investments reduced its Medpace (MEDP) stake by 66% in Q2 2026, selling an estimated $1.73M and leaving 1,907 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #1109.

Atria Investments first reported a position in MEDP in Q4 2017 and has held it in 14 quarters since. The position peaked at $3.04M in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Atria Investments held 1,907 shares of Medpace worth $1.01M as of Q2 2026.
  • Atria Investments sold 3,740 Medpace shares in Q2 2026, an estimated $1.73M.
  • Medpace made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1109 holding.
  • Atria Investments first reported a position in Medpace in Q4 2017 and has held it in 14 quarters since.
  • Atria Investments's Medpace position peaked at $3.04M in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.